Pathologic tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

Medicine, Oncology, Pharmacology +13

Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data

Monique Maas, Patty J. Nelemans, Vincenzo Valentini et al. · The Lancet Oncology · 2010 · 2K citations

Medicine, Oncology, Radiation Oncology +17

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

Matthew H. G. Katz, Peter W. T. Pisters, Douglas B. Evans et al. · Journal of the American College of Surgeons · 2008 · 820 citations · Full text

Medicine, Oncology, Surgery +13

Two Thousand Consecutive Pancreaticoduodenectomies

John L. Cameron, Jin He · Journal of the American College of Surgeons · 2015 · 618 citations

Medicine, Internal Medicine, Gastroenterology +4

Response of borderline resectable pancreatic cancer to neoadjuvant therapy is not reflected by radiographic indicators

Matthew H. G. Katz, Jason B. Fleming, Priya Bhosale et al. · Cancer · 2012 · 527 citations · Full text

Medicine, Oncology, Surgery +17